The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: II. Therapeutic Management of Atherogenic Dyslipidemia

類似資料

• The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes Mellitus
  著者:: Ginsberg, Henry N., 等
  出版事項: (2009)
• Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
  著者:: Tenenbaum, Alexander, 等
  出版事項: (2006)
• Approach to identifying and managing atherogenic dyslipidemia: A metabolic consequence of obesity and diabetes
  著者:: Bosomworth, N. John
  出版事項: (2013)
• Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
  著者:: Kumar, Ajoy, 等
  出版事項: (2010)
• The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus
  著者:: Mahran, Howayda N., 等
  出版事項: (2016)